Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bjorkander

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Normal and abnormal mucosal antibody mediated immunityJ Bjorkander, C Czerkinsky, U Dahlgren, et al.
Clinical and Experimental Immunology|November 28, 2002
Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish studyL Mellemkjaer, L Hammarstrom, V Andersen, et al.
Journal of Clinical Immunology|May 23, 2000
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyH M Chapel, G P Spickett, D Ericson, et al.
Journal of Hepatology|September 1, 1994
Hepatitis C virus transmission by intravenous immunoglobulinP L Yap, F McOmish, A D Webster, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Normal and abnormal mucosal antibody mediated immunityJ Bjorkander, C Czerkinsky, U Dahlgren, et al.
Clinical and Experimental Immunology|November 28, 2002
Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish studyL Mellemkjaer, L Hammarstrom, V Andersen, et al.
Journal of Clinical Immunology|May 23, 2000
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyH M Chapel, G P Spickett, D Ericson, et al.
Journal of Hepatology|September 1, 1994
Hepatitis C virus transmission by intravenous immunoglobulinP L Yap, F McOmish, A D Webster, et al.
Pageof 1